American Osteopathic Association

Advancing the distinctive philosophy and practice of osteopathic medicine

Request for Grant Applications

The AOA has identified five research priorities with the potential to impact patient care and evidence-based medicine and demonstrate the value of the osteopathic approach. 

Osteopathic Philosophy

RFA:​ Osteopathic Philosophy and Differences in Communication, Compassion/Empathy or Patient Satisfaction Grant

​C​hronic Diseases & Conditions

RFA: Osteopathic Approach to Obesity, its related Metabolic Disorders, and Complications​

  • ​​​​​​​​​​​​The AOA is seeking applications for research studies that address the unique osteopathic approach to address obesity and its related disorders​.  Both clinical and basic science proposals are eligible for this RFA.​

Osteopathic Manipulative Medicine/Osteopathic Manipulative Treatment (OMM/OMT)

RFA 1: OMT Effect on Inflammation

      • The AOA is seeking applications for research studies that address the effect of OMT on inflammationthrough clinical, in vitro, or basic science research, which shows clear relevance to disease states including, but not limited, to the following: acute or chronic musculoskeletal pain, chronic fatigue, fibromyalgia, asthma/COPD, infectious diseases, or other clinical conditions.

RFA 2: The Osteopathic Approach & Parkinson’s Disease

Musculosk​eletal Injuries and Prevention​

RFA: Osteopathic Medicine Applied to Musculoskeletal Injuries and Prevention

  • The AOA is seeking applications for research studies that address​​osteopathic medicine applied to musculoskeletal injuries and prevention​; the application of osteopathic medicine to musculoskeletal through clinical, in vivo (i.e. animal models), in vitro (i.e. cell-based), or other basic science research.

Pain Management

RFA: Chronic Pain Management

  • The AOA is seeking applications for research studies examining the osteopathic approach to chronic pain management and its effect on patient outcomes. Chronic pain​ is defined as pain that lasts more than three months.

Bureau of Scientific Affairs and Public Health

RFA: Red​ucing​ Nonmedical Use of Prescription Drugs

Deadline for Application

  • The deadline for all RFAs is Jan. 31, 2018 by 5 p.m. Central Time

  • Awards will be announced June 15, 2018

Application Process

Technical Assistance/Questions

Frequently Asked Questions (FAQs) for All AOA RFAs​​

Questions should be directed to the AOA Department of Research and Development at:

Gloria Dillard, MPH, Research Manager
Phone: (312) 202-8006
Fax: (312) 202-8306


 Share This